Grantham, Mayo, Van Otterloo & Co (GMO)’s Stride LRN Stock Holding History
Bought
Maintained
Sold
Other funds holding LRN
JT
IC
FCM
Grantham, Mayo, Van Otterloo & Co (GMO)'s LRN Position: Q2 2026 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) increased its Stride (LRN) stake by 29% in Q2 2026, buying an estimated $235K and bringing the position to 11,507 shares worth $992K. The position accounts for ﹤0.01% of the portfolio, ranked #521.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in LRN in Q4 2017 and has held it in 18 quarters since. The position peaked at $14.4M in Q1 2019. 413 funds tracked by Wall St. Rank hold LRN as of Q2 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) held 11,507 shares of Stride worth $992K as of Q2 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) bought 2,561 Stride shares in Q2 2026, an estimated $235K.
- Stride made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #521 holding.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Stride in Q4 2017 and has held it in 18 quarters since.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Stride position peaked at $14.4M in Q1 2019.
- 413 funds tracked by Wall St. Rank held Stride as of Q2 2026.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.